DermProducts

Syneron Medical Ltd., a leading medical aesthetic device innovator,
reports today the growing popularity of eMatrix™ amongst physicians
worldwide in safely and effectively treating all skin tones. Historically,
physicians have struggled to find treatments that could deliver significant
noticeable results for all skin tones while remaining gentle enough
to prevent adverse events. The most common dermatological concerns
for patients with darker skin tones, which include African-American,
Asian, Hispanic, East Indian and other darker skin type patients, are
scarring and discoloration.

Dr. Doris Day, an author and a board certified dermatologist at Day
Dermatology and Aesthetics in Manhattan, New York, recently appeared
on The View to demonstrate the latest aesthetic breakthroughs that
address the common concerns of her patients with ethnic skin tones.
Dr. Day noted, "It's important to use treatments that are designed with skin
of color in mind, otherwise there is a risk of increased scarring and
discoloration after the treatment." According to Dr. Day, Sublative
Rejuvenation with eMatrix is opening up a whole new world of safe and
efficacious treatments for patients with darker skin who previously
had limited options.

Sublative Rejuvenation, an entirely new treatment category in
energy-based facial rejuvenation, uses fractionated bi-polar radio
frequency (RF) energy to place the maximum amount of heat into the
dermal layer of the skin with minimal disruption of the epidermal
layer of the skin intact. "The innovative method of energy delivery
is what truly sets Sublative Rejuvenation apart from all the other
energy-based facial rejuvenation treatments," said Dr. Michael Gold,
a board certified dermatologist at the Gold Skin Care Center in
Nashville, Tennessee. "Now I can effectively treat challenging skin
irregularities like acne scars, and for the first time have the
freedom to safely treat my darker skin patients."

Sublative Rejuvenation with eMatrix is anticipated to be a one of the
leading topics at the upcoming IMCAS Asia conference, held in Hong
Kong, China in July. "Over the years, we've witnessed a number of
technologies that attempted to achieve the same effective and
reproducible results for ethnic skin patients as seen on lighter skin
patients," said Dr. Henry Chan, a dermatologist in Hong Kong, China.
"My clinical findings of Sublative Rejuvenation with eMatrix, which I
will present at IMCAS Asia, shows that it is truly one of the few
devices to safely and successfully induce skin rejuvenation,
especially acne scarring amongst my skin of color patients. It is
quite remarkable and I'm excited to see the expanded capabilities of
Sublative Rejuvenation beyond our current knowledge of this novel
treatment."

Attendees at the 2010 IMCAS Asia conference (imcas.com) can
obtain a demonstration and preview of multiple product offerings at
the Syneron and Candela booth #EO1.

About the eMatrix™
The eMatrix™ system with Syneron's unique
Sublative Rejuvenation treatment is the newest innovation in
energy-based facial rejuvenation. The system utilizes fractionated
bi-polar radio frequency (RF) technology -- to place the heat energy
effectively into the dermis where it can produce significant dermal
impact with minimal epidermal disruption. The eMatrix™ offers an
industry breakthrough intelligent feedback system that gives real
time feedback of skin condition (impedance) and actual energy
delivered. The addition of the evolutionary Sublative RF High Density
tip, which exemplifies eMatrix' continued commitment to scientific
advances, displays the true versatility and advancement of the
system, addressing multiple conditions from one system. The
treatments offer high dermal remodeling -- low downtime -- high
clinical result -- high patient satisfaction.

About Syneron Medical Ltd.
Syneron Medical Ltd., a company devoted to real science and results, is
The leading global aesthetic device company with a comprehensive
product portfolio and a global distribution footprint. The Company's
technology enables physicians to provide advanced solutions for a
broad range of medical-aesthetic applications including body
contouring, hair removal, wrinkle reduction, rejuvenation of the
skin's appearance through the treatment of superficial benign
vascular and pigmented lesions, and the treatment of acne, leg veins
and cellulite. The Company sells its products under two distinct
brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and
manufacturing headquarters for Syneron Medical Ltd. are located in
Israel. Syneron also has R&D and manufacturing operations in the US.
The company markets and services and supports its products in 86
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide.